Literature DB >> 12860279

Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer.

Jean M Nussbaum1, Marian Major, Shobha Gunnery.   

Abstract

PKR (double-stranded RNA activated protein kinase) is overexpressed and overactive in human breast carcinoma (BC) cells. Here, we report that BC cells also have higher PKR mRNA levels and exhibit increased transcription from the PKR promoter. Mutational analysis of the PKR promoter indicated that the interferon stimulation response element (ISRE) is responsible for the increased transcription in BC cells. By gel retardation assay, ISRE-protein complexes formed by BC and non-transformed nuclear extracts were compared. A BC-specific ISRE-protein complex resembles the multimeric factor, ISGF3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860279     DOI: 10.1016/s0304-3835(03)00276-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Pathway analysis using random forests with bivariate node-split for survival outcomes.

Authors:  Herbert Pang; Debayan Datta; Hongyu Zhao
Journal:  Bioinformatics       Date:  2009-11-18       Impact factor: 6.937

2.  Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses.

Authors:  S Bhattacharya; W-C HuangFu; G Dong; J Qian; D P Baker; J Karar; C Koumenis; J A Diehl; S Y Fuchs
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

3.  Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity.

Authors:  Abujiang Pataer; Stephen G Swisher; Jack A Roth; Christopher J Logothetis; Paul G Corn
Journal:  Cancer Biol Ther       Date:  2009-02-08       Impact factor: 4.742

Review 4.  Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy.

Authors:  Serge Y Fuchs
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

Review 5.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

6.  Increased expression of the dsRNA-activated protein kinase PKR in breast cancer promotes sensitivity to doxorubicin.

Authors:  Richard L Bennett; Aubrey L Carruthers; Teng Hui; Krystal R Kerney; Xiangfei Liu; W Stratford May
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

7.  Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis.

Authors:  Amal A Mohamed; Ola H Nada; Mohamed A El Desouky
Journal:  Diagn Pathol       Date:  2012-08-15       Impact factor: 2.644

8.  CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.

Authors:  Xiaolong Wang; Tong Chen; Chen Li; Wenhao Li; Xianyong Zhou; Yaming Li; Dan Luo; Ning Zhang; Bing Chen; Lijuan Wang; Wenjing Zhao; Shanji Fu; Qifeng Yang
Journal:  J Hematol Oncol       Date:  2022-08-29       Impact factor: 23.168

9.  Double-stranded RNA-dependent protein kinase regulates the motility of breast cancer cells.

Authors:  Mei Xu; Gang Chen; Siying Wang; Mingjun Liao; Jacqueline A Frank; Kimberly A Bower; Zhuo Zhang; Xianglin Shi; Jia Luo
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Importance of the interferon-alpha system in murine large intestine indicated by microarray analysis of commensal bacteria-induced immunological changes.

Authors:  Kaori Munakata; Masahiro Yamamoto; Naoko Anjiki; Mitsue Nishiyama; Sachiko Imamura; Seiichi Iizuka; Kiyoe Takashima; Atsushi Ishige; Kyoji Hioki; Yasuyuki Ohnishi; Kenji Watanabe
Journal:  BMC Genomics       Date:  2008-04-26       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.